Medical hollow photo-thermal glass bead for photo-thermal therapy
By preparing spherical hollow glass microspheres composed of TiO2 and TiN, the problems of water solubility, stability and shape of existing photothermal agent materials were solved, achieving good fluidity and positioning in photothermal therapy, thus improving the therapeutic effect and safety.
Patent Information
- Application Number
- CN202411018728.7
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-29
- Publication Date
- 2024-11-22
- Estimated Expiration
- Not applicable · inactive patent
AI Technical Summary
Existing photothermal materials have problems in photothermal therapy, such as poor water solubility, poor photothermal stability, high density, irregular shape leading to vascular deposition and damage, and difficulty in long-distance transportation and positioning.
A glass microsphere formulation combining TiO2 and TiN was developed, and spherical hollow glass microspheres were prepared by high-temperature spheroidization. A foaming agent was added to control the density, achieving photothermal conversion and biocompatibility. This resulted in the preparation of medical hollow photothermal glass microspheres with good flowability and no toxic side effects.
It achieves smooth flow and precise positioning in blood vessels, improves the therapeutic effect of photothermal therapy, reduces the risk of damage to blood vessels, and has good biocompatibility and chemical stability.
Smart Images

Figure CN118987206A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the technical field of biomedical materials, and in particular to a medical hollow photothermal glass microbead for photothermal therapy. Background Art
[0002] With the rapid development of medical technology, photothermal therapy has become a new type of tumor cell treatment method with its advantages of convenient operation, little damage to the human body, and the ability to treat inside human organs. It is becoming a hot topic in scientific research. Photothermal therapy is a photon-triggered treatment method that kills tumor cells through local high temperatures generated by materials with photothermal effects under visible or near-infrared light excitation. At present, there have been many related studies on photothermal therapy. The materials used in photothermal therapy have good photothermal conversion rates and are mostly non-toxic and easy to functionalize.
[0003] At present, photothermal agents can be divided into three categories: (1) inorganic particles; (2) organic small molecules; (3) conjugated polymers with large π bonds. Among them, organic small molecules have problems such as poor water solubility and poor photothermal stability. Conjugated polymers with large π bonds have strong absorption in the near-infrared band, but because they are difficult to effectively degrade under the physiological environment of the human body, they have long-term toxic side effects, which limits their development. Inorganic particles are highly stable and biosafe and can be used as biomedical materials. However, due to the high density and irregular shape of inorganic particles, they will quickly settle to the bottom of the blood vessels when injected into the blood vessels. The irregular shape will also cause damage to the blood vessels, which is not conducive to long-distance transportation, positioning and safe use, and will greatly reduce the treatment effect. Summary of the invention
[0004] In order to make up for the defects of the prior art, the purpose of the present invention is to provide a medical hollow photothermal glass microsphere for photothermal therapy: (1) by adding a formula component with photothermal conversion effect, the glass microsphere is endowed with photothermal conversion ability; (2) by adding a foaming agent to the glass formula to prepare hollow glass microspheres, spherical hollow glass microspheres with cavities and adjustable density are obtained, which can flow smoothly in blood vessels and achieve precise positioning. Finally, the preparation of medical hollow photothermal glass microspheres with good fluidity, high biocompatibility and chemical stability, and no toxic side effects is achieved.
[0005] The purpose of the present invention can be achieved through the following technical solutions:
[0006] A medical hollow photothermal glass microsphere for photothermal therapy, comprising a glass microsphere body and a cavity arranged inside the glass microsphere body, wherein the glass microsphere body has a photothermal conversion effect, and the density of the hollow photothermal glass microsphere can achieve 1g / cm 3 -2.2g / cm 3 Density control.
[0007] TiN is an important new inorganic functional material that can produce surface plasmon effects in the visible light band and longer bands, achieving efficient absorption in the visible light and near-infrared bands. TiO2 has a wide band gap and can absorb ultraviolet light. Combining TiO2 and TiN can take advantage of their absorption advantages in different bands to achieve efficient absorption in a wide band or even the entire band.
[0008] The glass microsphere body includes SiO2, B2O3, CaO, TiO2, TiN, R2O and other components, and the specific composition by mass percentage is as follows:
[0009]
[0010] The above-mentioned medical hollow photothermal glass microspheres are prepared by the following steps:
[0011] (1) According to the proportion, SiO2, B2O3, CaO, TiO2, TiN, R2O and foaming agent are weighed respectively. First, nano-TiO2 and TiN powders are fully premixed, and then the premixed powders are fully mixed with other components until they are uniform. The final mixture is added to a crucible and placed in a high-temperature vacuum furnace for melting. The temperature is raised from room temperature to 1000-1500°C and kept warm. Then, the glass liquid is water quenched to obtain cullet. The cullet is placed in a dryer for drying at a temperature of 200-300°C.
[0012] (2) Grinding the dried broken glass, sieving the ground glass raw powder with a standard sieve, and feeding it into a hollow spheroidizing furnace through a feeder for spheroidizing treatment at a spheroidizing temperature of 1200 to 1400°C.
[0013] (3) The final product is collected for cleaning, rinsing, selection and drying, and then sieved again with a standard sieve to obtain the finished hollow glass microspheres.
[0014] Beneficial effects of the present invention:
[0015] (1) By adding TiO2 and TiN components with photothermal effect into the formula, the glass microspheres can be endowed with photothermal conversion ability, thereby realizing the preparation of medical hollow photothermal glass microspheres that can be used for photothermal therapy;
[0016] (2) Spherical glass microbeads made by high-temperature spheroidization have better fluidity in human blood than other shapes;
[0017] (3) Adding a foaming agent makes the glass microspheres hollow, reducing the density of the spheres, and the density of the glass microspheres can be adjusted within a certain range by controlling the foaming process, thereby regulating the flow of the glass microspheres in the blood;
[0018] (4) This method is simple and efficient, and the product obtained is stable and controllable, with promising prospects for medical applications. BRIEF DESCRIPTION OF THE DRAWINGS
[0019] The present invention will be further described below in conjunction with the accompanying drawings.
[0020] Figure 1 This is the SEM image of the hollow glass microspheres prepared in Example 1.
[0021] Figure 2 Schematic diagram of photothermal conversion test.
[0022] Figure 3 This is a curve diagram of the temperature change of the hollow glass microspheres of Example 1 over time under light conditions. DETAILED DESCRIPTION
[0023] The following will be combined with the embodiments of the present invention to clearly and completely describe the technical solutions in the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.
[0024] Example 1
[0025] Calculated by weight, weigh 32.5kg of SiO2, 6kg of B2O3, 3kg of CaO, 4kg of TiO2, 4kg of TiN, 0.1kg of R2O, and 0.4kg of foaming agent (all raw materials used are analytically pure and purchased from Sinopharm Chemical Reagent Co., Ltd.). Premix the nano-TiO2 and TiN powders thoroughly, and then mix the premixed powders with other components until they are uniform. Add the final mixture to a crucible and place it in a high-temperature vacuum furnace for melting. Heat the temperature from room temperature to 1400°C at a heating rate of 5°C / min and keep it warm for four hours. The glass liquid is water quenched to obtain broken glass, and the broken glass is placed in a dryer for drying.
[0026] The dried broken glass is ground in a jet mill, and the ground powder is sieved with a standard sieve to select the appropriate particle size for the subsequent spheroidization process. The spheroidization furnace is preheated, and the glass powder is sent to the flame spheroidization furnace with nitrogen as the carrier gas. The temperature of the spheroidization furnace is controlled at 1200-1400℃. The irregularly shaped glass powder will melt, and the foaming agent will decompose to release gas to form a cavity, and the microspheres will be collected in the flame spheroidization furnace collector.
[0027] The final product is cleaned, rinsed, and dried to obtain medical hollow glass microspheres with suitable particle size density and photothermal conversion effect. Figure 1 The following is a SEM picture of the hollow glass microspheres prepared in this embodiment.
[0028] use Figure 2 The device shown in the figure is used to test the photothermal conversion effect. When the sample is irradiated by a light source (wavelength range is 700-1200nm), as the irradiation time increases, the sample temperature gradually increases, but the temperature increase amplitude becomes smaller and smaller. A temperature value is collected every 30s to obtain the following Figure 3 Before the irradiation, the temperature was 26.5℃. After a certain period of irradiation, when the temperature tended to be stable, the highest temperature was 61.3℃, and the temperature rise was 34.8℃.
[0029] Example 2
[0030] The difference between this embodiment and embodiment 1 is that the raw material ratio is different. By weight, 32.5kg SiO2, 6kg B2O3, 3kg CaO, 3kg TiO2, 5kg TiN, 0.1kg R2O and 0.4kg foaming agent are weighed. Nano-grade TiO2 and TiN powders are fully premixed, and the premixed powders are fully mixed with other components until uniform. The final mixture is added to a crucible and placed in a high-temperature vacuum furnace for melting. The temperature is raised from room temperature to 1400°C at a heating rate of 5°C / min and kept warm for four hours. The glass liquid is water quenched to obtain broken glass, and the broken glass is placed in a dryer for drying.
[0031] Example 3
[0032] The difference between this embodiment and embodiment 1 is that the amount of foaming agent used is different, and 0.2 kg of foaming agent is taken for full mixing. The spheroidizing furnace is preheated, and the glass powder is sent to the flame spheroidizing furnace with nitrogen as the carrier gas. The temperature of the spheroidizing furnace is controlled at 1200-1400°C, and the spheroidizing time is 0.5 seconds. The irregularly shaped glass powder will melt, and the foaming agent will decompose and release gas to form a cavity, and the microspheres are collected in the flame spheroidizing furnace collector.
[0033] Example 4
[0034] The difference between this embodiment and embodiment 1 is that the type of foaming agent is different, and 0.4 kg of calcium sulfate CaSO4 is taken and mixed thoroughly.
[0035] Density and particle size tests were performed on samples of Examples 1, 2, 3, and 4, and the results are shown in the following table:
[0036]
[0037] The above specific implementation method part specifically introduces the analytical method involved in the present invention. It should be noted that the above introduction is only to help those skilled in the art better understand the method and ideas of the present invention, rather than limiting the relevant content. Without departing from the principle of the present invention, those skilled in the art may also make appropriate adjustments or modifications to the present invention, and the above adjustments and modifications shall also fall within the scope of protection of the present invention.
Claims
1. A medical hollow photothermal glass microsphere for photothermal therapy, characterized in that: The invention comprises a glass microsphere body and a cavity arranged inside the glass microsphere body, wherein the glass microsphere body has a light-heat conversion effect.
2. The medical hollow photothermal glass microsphere for photothermal therapy according to claim 1, characterized in that: The glass microsphere body includes the following chemical compositions by mass percentage:
3. The medical hollow photothermal glass microsphere for photothermal therapy according to claim 2, characterized in that: R is Na or Li.
4. The medical hollow photothermal glass microsphere for photothermal therapy according to claim 1, characterized in that: The density of the hollow photothermal glass microspheres can be 1g / cm 3 -2.2g / cm 3 Density control.
5. The medical hollow photothermal glass microsphere for photothermal therapy according to claim 2, characterized in that: Prepared by the following steps: (1) Weighing SiO2, B2O3, CaO, TiO2, TiN, R2O and a foaming agent according to a ratio, first premixing nano-TiO2 and TiN powders, then mixing the premixed powders with other components until they are uniform, adding the final mixture into a crucible, placing it in a high-temperature vacuum furnace for melting, heating it from room temperature to 1000-1500° C. and keeping it warm, then quenching the glass liquid with water to obtain cullet, and placing the cullet in a dryer for drying; (2) Grinding the dried cullet, sieving the ground glass powder with a standard sieve, and feeding the cullet powder into a hollow spheroidizing furnace through a feeder for spheroidization treatment; (3) The final product is collected for cleaning, rinsing, selection and drying, and then sieved again with a standard sieve to obtain the finished hollow glass microspheres.
6. The medical hollow photothermal glass microsphere for photothermal therapy according to claim 5, characterized in that: The drying temperature in step (1) is between 200 and 300°C.
7. The medical hollow photothermal glass microsphere for photothermal therapy according to claim 5, characterized in that: In step (2), the spheroidization temperature is between 1200 and 1400°C.
Citation Information
Patent Citations
Glass microballoon manufacturing device and preparation method thereof
CN102417291A
Injectable composite bone cement with photothermal effect as well as preparation method and application thereof
CN111012951A
Radioembolism glass microsphere as well as preparation method and application thereof
CN115645552A
Phosphate glass with photothermal effect and preparation method and application thereof
CN116002976A
Photothermal transducing particles, image forming material using the same and its production
JP2001005177A
